Physician profile
Michael A Denz
NPI 1992154819
$6,444.15
in general payments reported to CMS, 2019-2025
11 companies · $512 in 2025
The $512 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $24.32 · 2021: $2,322 · 2022: $2,700 · 2023: $36.84 · 2024: $194 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,904.68 | 2022-2025 | Aequalis Perform Reversed, Bio4, Inspace |
| Djo, LLC | $2,071.68 | 2021 | |
| Medwest Associates | $527.00 | 2019 | |
| Depuy Synthes Sales INC. | $450.29 | 2022-2025 | Na, Tfn-Advance |
| Encore Medical, LP | $129.25 | 2021 | |
| Vericel Corporation | $121.36 | 2021 | |
| Medtronic USA, INC. | $77.08 | 2019 | |
| Orthofix Medical, INC. | $74.58 | 2022-2025 | Physio-Stim |
| Boston Scientific Corporation | $50.31 | 2019 | |
| Mallinckrodt Hospital Products INC. | $24.32 | 2020 | |
| Paratek Pharmaceuticals, INC. | $13.60 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Denz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.